>全球 Certolizumab Pegol 市场，按类型（单剂量小瓶、单剂量预充注射器）、应用（克罗恩病、活动性银屑病关节炎、类风湿性关节炎、强直性脊柱炎、斑块性银屑病、轴性脊柱关节炎、其他）、剂型（溶液、注射剂、其他）、给药途径（皮下、其他）、最终用户（诊所、医院、其他）、分销渠道（医院药房、零售药房、网上药房）、国家（美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区）行业趋势及预测（至 2029 年）
市场分析和洞察：全球赛妥珠单抗市场
预计 Certolizumab pegol 市场将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 3%。
赛妥珠单抗是一种治疗中度至重度类风湿性关节炎、银屑病关节炎、强直性脊柱炎和克罗恩病的药物。它有助于缓解疲劳、疼痛、关节肿胀和早晨僵硬等症状。Cimzia 是赛妥珠单抗的品牌名。它是一种生物制剂，属于抗 TNF 或 TNF 阻滞剂类药物。
类风湿性关节炎患病率上升和医疗支出上升是影响市场增长率的主要因素。此外，老年人口增加和临床试验研究数量的激增是扩大赛妥珠单抗市场的因素。其他因素包括政府举措的增加和意识的提高，将对市场增长率产生积极影响。
此外，研发活动和正在进行的临床试验的增加将为 2022-2029 年预测期内的 certolizumab pegol 市场提供有利的机会。
然而，产品成本高昂以及过敏反应、头晕和血液问题等副作用将阻碍市场增长。缺乏认知将在上述预测期内进一步挑战赛妥珠单抗市场。
This certolizumab pegol market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the certolizumab pegol market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Certolizumab Pegol Market Scope and Market Size
The certolizumab pegol market is segmented on the basis of type, application, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the certolizumab pegol market is segmented into single-dose vial and single-dose prefilled syringe.
- On the basis of application, the certolizumab pegol market is segmented into Crohn’s disease, active psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, axial spondyloarthritis and others.
- On the basis of dosage form, the certolizumab pegol market is segmented into solution, injection and others.
- On the basis of route of administration, the certolizumab pegol market is segmented into subcutaneous and others.
- On the basis of end-users, the certolizumab pegol market is segmented into clinic, hospital and others.
The certolizumab pegol market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.
Certolizumab Pegol Market Country Level Analysis
Certolizumab pegol market is analyzed and market size information is provided by the country, type, application, dosage form, route of administration, end-users and distribution channel as referenced above.
The countries covered in the certolizumab pegol market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
由于北美拥有主要关键参与者、高可支配收入和发达的医疗保健基础设施，北美在赛妥珠单抗市场占据主导地位。由于亚太地区研发活动的增加和类风湿性关节炎患病率的上升，预计该地区在 2022-2029 年的预测期内将实现增长。
报告的国家部分还提供了影响单个市场因素和国内市场法规变化，这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。
患者流行病学分析
Certolizumab pegol 市场还为您提供详细的市场分析，用于患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响，以创建更稳健和队列多元统计模型，用于预测增长期的市场。
竞争格局和全球赛妥珠单抗市场份额分析
赛妥珠单抗市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对赛妥珠单抗市场研究的关注有关。
certolizumab pegol 市场的一些主要参与者包括 UCB SA、LGM Pharma、ADM、BASF SE、Cargill Incorporated、Land O'Lakes, Inc.、Dallas Keith、Agridyne LLC、Ridley Corporation Limited 和 Liquid Feeds Inc. 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
